CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-04 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −1,385 | $6.73 | $9K | 65,117 |
| 2024-01-04 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | ||
| 2024-01-04 | Brazzell Romulus K SEE REMARKS | Grant or award | +6,500 | 93,090 | ||
| 2024-01-04 | Brazzell Romulus K SEE REMARKS | Sale | −1,617 | $6.74 | $11K | 91,473 |
| 2024-01-04 | Brazzell Romulus K SEE REMARKS | Grant or award · Stock Option (right to buy) | +29,300 | 29,300 | ||
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +14,300 | 290,854 | ||
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −4,539 | $6.73 | $31K | 286,315 |
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +64,500 | 64,500 | ||
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +4,600 | 67,363 | ||
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −1,227 | $6.74 | $8K | 66,136 |
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | ||
| 2024-01-04 | Bazemore Todd SEE REMARKS | Grant or award | +6,500 | |||
| 2024-01-04 | Bazemore Todd SEE REMARKS | Sale | −1,405 | $6.74 | $9K | |
| 2024-01-04 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (right to buy) | +29,300 | 29,300 | ||
| 2023-06-22 | Farid Marjan Director | Grant or award | +3,692 | 5,292 | ||
| 2023-06-22 | Farid Marjan Director | Grant or award | +1,100 | 6,392 | ||
| 2023-06-22 | Farid Marjan Director | Grant or award · Stock Option (right to buy) | +4,922 | 4,922 | ||
| 2023-06-22 | Farid Marjan Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-06-22 | Rosen Howard B Director | Grant or award | +7,988 | 11,387 | ||
| 2023-06-22 | Rosen Howard B Director | Grant or award | +1,100 | 12,487 |
Page 5 of 12 · 236 trades